BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Hoffmann-La Roche
Endeavor Biomedicines, Inc.
OHSU Knight Cancer Institute
MacroGenics
DualityBio Inc.
Daiichi Sankyo
ImmunityBio, Inc.
National Cancer Institute (NCI)
Mayo Clinic
Bayer
M.D. Anderson Cancer Center
Tempus AI
Day One Biopharmaceuticals, Inc.
Oslo University Hospital
Iovance Biotherapeutics, Inc.
University Medical Center Groningen
Vyriad, Inc.
Providence Health & Services
Seagen Inc.
University of Pittsburgh
Novartis
IO Biotech
Providence Health & Services
Jules Bordet Institute
Oncovir, Inc.
GE Healthcare
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)